(Q38049332)

27 August 2017

Therapeutic options for Acinetobacter baumannii infections: an update (English)

1 reference

27 August 2017

Acinetobacter baumannii

1 reference

Jordi Vila

1

0 references

author name string

Jerónimo Pachón

series ordinal

2

1 reference

PubMed ID

23035697

27 August 2017

language of work or name

English

0 references

publication date

4 October 2012

1 reference

Expert Opinion on Pharmacotherapy

27 August 2017

1 reference

27 August 2017

13

1 reference

27 August 2017

16

1 reference

27 August 2017

2319-2336

1 reference

Acinetobacter baumannii: emergence of a successful pathogen

27 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Clinical impact and molecular basis of antimicrobial resistance in non-baumannii Acinetobacter

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. nov. (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp. nov. (forme

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Effect of biofilm formation on the survival of Acinetobacter baumannii on dry surfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Evolution of antimicrobial resistance of Acinetobacter baumannii in a university hospital.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Trends in antimicrobial resistance of Acinetobacter baumannii isolates from a metropolitan Detroit health system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Independent emergence of colistin-resistant Acinetobacter spp. isolates from Korea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Acinetobacter baumannii Resistant to Colistin With Impaired Virulence: A Case Report From France

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Genetic features of CTX-M-15-producing Acinetobacter baumannii from Haiti

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Detection of CTX-M-15-producing and carbapenem-resistant Acinetobacter baumannii strains from urine from an Indian hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Detection of KPC in Acinetobacter spp. in Puerto Rico

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Updated functional classification of beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

NDM-2 carbapenemase in Acinetobacter baumannii from Egypt

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Emergence of NDM-1-producing Acinetobacter baumannii in China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Molecular characterization of blaNDM-1 in an Acinetobacter baumannii strain isolated in Germany in 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Dissemination of an NDM-2-producing Acinetobacter baumannii clone in an Israeli rehabilitation center

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Widespread occurrence of aminoglycoside resistance due to ArmA methylase in imipenem-resistant Acinetobacter baumannii isolates in China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

AdeIJK, a resistance-nodulation-cell division pump effluxing multiple antibiotics in Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Activities of colistin- and minocycline-based combinations against extensive drug resistant Acinetobacter baumannii isolates from intensive care unit patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Changes in MIC within a global collection of Acinetobacter baumannii collected as part of the Tigecycline Evaluation and Surveillance Trial, 2004 to 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Distribution of tetracycline resistance genes in genotypically related and unrelated multiresistant Acinetobacter baumannii strains from different European hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

The pmrCAB operon mediates polymyxin resistance in Acinetobacter baumannii ATCC 17978 and clinical isolates through phosphoethanolamine modification of lipid A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Insertion sequence ISAba11 is involved in colistin resistance and loss of lipopolysaccharide in Acinetobacter baumannii.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

The cost of resistance to colistin in Acinetobacter baumannii: a proteomic perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Nosocomial outbreak of infection with pan-drug-resistant Acinetobacter baumannii in a tertiary care university hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

The epidemiology and control of Acinetobacter baumannii in health care facilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Clinical impact of pneumonia caused by Acinetobacter baumannii in intubated patients: a matched cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Treatment of multidrug-resistant Acinetobacter baumannii meningitis with ampicillin/sulbactam

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Impact of inappropriate antimicrobial therapy on outcome in patients with hospital-acquired pneumonia caused by Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Impact of carbapenem resistance and receipt of active antimicrobial therapy on clinical outcomes of Acinetobacter baumannii bloodstream infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Therapeutic options for Acinetobacter baumannii infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Severe nosocomial infections with imipenem-resistant Acinetobacter baumannii treated with ampicillin/sulbactam

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Clonal diversity and antimicrobial susceptibility of Acinetobacter baumannii isolated in Spain. A nationwide multicenter study: GEIH-Ab project (2000)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Sulbactam efficacy in experimental models caused by susceptible and intermediate Acinetobacter baumannii strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Pharmacodynamic assessment of Amoxicillin-Sulbactam against Acinetobacter baumannii: searching the optimal dose and infusion time through a human ex-vivo model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

In vitro postantibiotic effect of colistin on multidrug-resistant Acinetobacter baumannii.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Colistin heteroresistance in acinetobacter and its association with previous colistin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Safety and effectiveness of colistin compared with tobramycin for multi-drug resistant Acinetobacter baumannii infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Potential for underdosing and emergence of resistance in Acinetobacter baumannii during treatment with colistin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Cerebrospinal fluid penetration and pharmacokinetic/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Successful treatment of multidrug-resistant Acinetobacter baumannii ventriculitis with intravenous and intraventricular colistin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Cure of multiresistant Acinetobacter baumannii central nervous system infections with intraventricular or intrathecal colistin: case series and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Post-neurosurgical multidrug-resistant Acinetobacter baumannii meningitis successfully treated with intrathecal colistin. A new case and a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Intrathecal colistin for drug-resistant Acinetobacter baumannii central nervous system infection: a case series and systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Practice guidelines for the management of bacterial meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

New information about the polymyxin/colistin class of antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Activity of tigecycline (GAR-936) against Acinetobacter baumannii strains, including those resistant to imipenem

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Antimicrobial susceptibility among Acinetobacter calcoaceticus-baumannii complex and Enterobacteriaceae collected as part of the Tigecycline Evaluation and Surveillance Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Comprehensive assessment of tigecycline activity tested against a worldwide collection of Acinetobacter spp. (2005-2009).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Influence of testing methodology on the tigecycline activity profile against presumably tigecycline-non-susceptible Acinetobacter spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

In vitro activity of tigecycline against gram-positive and gram-negative pathogens as evaluated by broth microdilution and Etest

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Rapid development of Acinetobacter baumannii resistance to tigecycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

A review of clinical and microbiological outcomes following treatment of infections involving multidrug-resistant Acinetobacter baumannii with tigecycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Antimicrobial treatment and clinical outcomes of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

The clinical implication and prognostic predictors of tigecycline treatment for pneumonia involving multidrug-resistant Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Late onset ventilator-associated pneumonia due to multidrug-resistant Acinetobacter spp.: experience with tigecycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Pharmacokinetic considerations regarding tigecycline for multidrug-resistant (MDR) Klebsiella pneumoniae or MDR Acinetobacter baumannii urosepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Treatment of recurrent urosepsis with tigecycline: a pharmacological perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Tigecycline use in two cases with multidrug-resistant Acinetobacter baumannii meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Cerebral spinal fluid penetration of tigecycline in a patient with Acinetobacter baumannii cerebritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Low tigecycline concentrations in the cerebrospinal fluid of a neutropenic patient with inflamed meninges

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Pharmacokinetic/pharmacodynamic assessment of the in-vivo efficacy of imipenem alone or in combination with amikacin for the treatment of experimental multiresistant Acinetobacter baumannii pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Experience with extended-infusion meropenem in the management of ventilator-associated pneumonia due to multidrug-resistant Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Efficacy of rifampin and its combinations with imipenem, sulbactam, and colistin in experimental models of infection caused by imipenem-resistant Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Combination carbapenem-sulbactam therapy for critically ill patients with multidrug-resistant Acinetobacter baumannii bacteremia: four case reports and an in vitro combination synergy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Efficacy of colistin versus beta-lactams, aminoglycosides, and rifampin as monotherapy in a mouse model of pneumonia caused by multiresistant Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Rifampicin/imipenem combination in the treatment of carbapenem-resistant Acinetobacter baumannii infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Successful treatment of Acinetobacter meningitis with meropenem and rifampicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Combined colistin and rifampicin therapy for carbapenem-resistant Acinetobacter baumannii infections: clinical outcome and adverse events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

In vitro activity of teicoplanin combined with colistin versus multidrug-resistant strains of Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Potent synergy and sustained bactericidal activity of a vancomycin-colistin combination versus multidrug-resistant strains of Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

In vivo efficacy of glycopeptide-colistin combination therapies in a Galleria mellonella model of Acinetobacter baumannii infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Comparative activities of polycationic peptides and clinically used antimicrobial agents against multidrug-resistant nosocomial isolates of Acinetobacter baumannii.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Antimicrobial properties of brevinin-2-related peptide and its analogs: Efficacy against multidrug-resistant Acinetobacter baumannii.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Efficacy of six frog skin-derived antimicrobial peptides against colistin-resistant strains of the Acinetobacter baumannii group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Analogues of the frog skin peptide alyteserin-2a with enhanced antimicrobial activities against Gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant Acinetobacter baumannii.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Therapeutic efficacy of buforin II and rifampin in a rat model of Acinetobacter baumannii sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Studies on the antimicrobial activity of cecropin A-melittin hybrid peptides in colistin-resistant clinical isolates of Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

In vitro activity and potency of an intravenously injected antimicrobial peptide and its DL amino acid analog in mice infected with bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Efficacy of cecropin A-melittin peptides on a sepsis model of infection by pan-resistant Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Intramuscularly administered peptide A3-APO is effective against carbapenem-resistant Acinetobacter baumannii in mouse models of systemic infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Preclinical advantages of intramuscularly administered peptide A3-APO over existing therapies in Acinetobacter baumannii wound infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Antibacterial evaluation of a collection of norfloxacin and ciprofloxacin derivatives against multiresistant bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Thiophenyl oxime-derived phosphonates as nano-molar class C beta-lactamase inhibitors reducing MIC of imipenem against Pseudomonas aeruginosa and Acinetobacter baumannii.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

The use of nitric oxide releasing nanoparticles as a treatment against Acinetobacter baumannii in wound infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Photodynamic therapy for Acinetobacter baumannii burn infections in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Long-term control of hospital-wide, endemic multidrug-resistant Acinetobacter baumannii through a comprehensive "bundle" approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Prevalencia de los genes tetA y tetB como mecanismo de resistencia a tetraciclina y minociclina en aislamientos clínicos de Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Mechanism of action of and resistance to quinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Pre-clinical studies of a new quinolone (UB-8902) against Acinetobacter baumannii resistant to ciprofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Acinetobacter baumannii resistant to everything: what should we do?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.729820

10.1517/14656566.2012.729820

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference

PubMed ID

23035697